News

alse-colored scanning electron microscope image of dozens of microneedles arranged in a grid

Pinpointing Solutions for Cancer Detection

MIT Spectrum

Ovarian cancer is notoriously hard to detect. Lacking in reliable diagnostic or screening techniques and opaque in its biological origins, it is difficult to find or target until it has progressed to dangerously late stages. The Hammond and Irvine Labs, in conjunction with their clinical collaborators and a cohort of patients, are determined to change this.

Drawing on years of expertise in engineering, immunology, and materials chemistry, and on recent funding from the Bridge Project, a multi-disciplinary team of researchers has built a polymer microneedle patch that samples interstitial fluid in the body to screen for microRNAs from cancer cells. The patch, which also has applications for autoimmune diseases, could one day become the first noninvasive screening tool for ovarian cancer.

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

National Medal of Science Awarded to Rudolf Jaenisch

MIT News

Koch Institute member Rudolf Jaenisch has been recognized for his work that has led to major advances in our understanding of mammalian cloning and embryonic stem cells.

KI Director to be Named to National Cancer Advisory Board

The White House

In the White House announcement of his appointment, Koch Institute Director Tyler Jacks was recognized by the President for his depth of experience and tremendous dedication to cancer research.

Koch Institute and OMJP launch TRANSCEND

MIT News

KI announced a major strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals, Inc., and its affiliates, called TRANSCEND, whereby the parties will begin to collaborate in multiple areas of oncology research and technology development.

KI to host a new Center for Cancer Systems Biology

MIT News

This past week, the David H. Koch Institute for Integrative Cancer Research at MIT received funding from the National Cancer Institute (NCI) to become a Center for Cancer Systems Biology (CCSB). These centers are part of NCI's Integrative Cancer Biology Program (ICBP), which is the NCI's primary effort in cancer systems biology, a field that is rapidly seen as an essential component in the future of cancer research.

Koch Institute collaborative teams expand to include physicists

MIT News

Cancer research has traditionally been the realm of biologists, and, more recently, engineers. Now, physicists are getting in on the action. MIT has been awarded a five-year grant from the National Cancer Institute (NCI) to start a new Physical Science-Oncology Center. The funding, approximately $3.5 million per year, will support four cancer research projects led by MIT physical scientists.

David H. Koch Gives $100 Million to MIT for Cancer Research

MIT News

MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease.